Cargando…

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge

BACKGROUND: Induction of broadly neutralizing antibodies, such as the monoclonal antibodies IgGb12, 2F5 and 2G12, is the objective of most antibody-based HIV-1 vaccine undertakings. However, despite the relative conserved nature of epitopes targeted by these antibodies, mechanisms underlying the sen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borggren, Marie, Repits, Johanna, Sterjovski, Jasminka, Uchtenhagen, Hannes, Churchill, Melissa J., Karlsson, Anders, Albert, Jan, Achour, Adnane, Gorry, Paul R., Fenyö, Eva Maria, Jansson, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116816/ https://www.ncbi.nlm.nih.gov/pubmed/21698221 http://dx.doi.org/10.1371/journal.pone.0020135

Ejemplares similares

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression
por: Borggren, Marie, et al.
Publicado: (2008)

Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms
por: Cashin, Kieran, et al.
Publicado: (2014)

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies
por: Chikere, Kelechi, et al.
Publicado: (2014)

Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125
por: Uchtenhagen, Hannes, et al.
Publicado: (2011)

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
por: Gray, Lachlan, et al.
Publicado: (2011)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

CoRSeq(V3-C): a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm
por: Cashin, Kieran, et al.
Publicado: (2013)

HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs
por: Szojka, Zsófia Ilona, et al.
Publicado: (2022)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
por: Özkaya Şahin, Gülşen, et al.
Publicado: (2010)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
por: Fenyö, E, et al.
Publicado: (2009)

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
por: Sterjovski, Jasminka, et al.
Publicado: (2007)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012)

P20-08. Glycosylation: an important factor in Env diversity
por: Desaire, H, et al.
Publicado: (2009)

Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
por: Cashin, Kieran, et al.
Publicado: (2013)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
por: McGuire, Andrew T., et al.
Publicado: (2016)

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model
por: Siracusano, Gabriel, et al.
Publicado: (2021)

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
por: Heß, Rebecca, et al.
Publicado: (2019)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies
por: Mohan, Teena, et al.
Publicado: (2018)

Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency
por: Karlsson, Ulf, et al.
Publicado: (2016)

Designing a Multimer Allergen for Diagnosis and Immunotherapy of Dog Allergic Patients
por: Nilsson, Ola B., et al.
Publicado: (2014)

Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection
por: Mandizvo, Tawanda, et al.
Publicado: (2022)

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source
por: Gray, Lachlan, et al.
Publicado: (2007)

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
por: Sanders, Rogier W., et al.
Publicado: (2013)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants
por: Margolin, Emmanuel, et al.
Publicado: (2022)

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
por: Borm, Katharina, et al.
Publicado: (2016)

Envés
por: Amara, Luigi, 1971-
Publicado: (2003)

Glycosylation Tunes Neuroserpin Physiological and Pathological Properties
por: Visentin, Cristina, et al.
Publicado: (2020)

Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage
por: Finkelstein, Maxwell T., et al.
Publicado: (2022)

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes
por: Cashin, Kieran, et al.
Publicado: (2015)

Env-Specific Antibodies in Chronic Infection versus in Vaccination
por: Soldemo, Martina, et al.
Publicado: (2017)

Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env
por: Hodge, Edgar A., et al.
Publicado: (2022)

Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
por: Struwe, Weston B., et al.
Publicado: (2018)

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition
por: Sheik-Khalil, Enas, et al.
Publicado: (2014)

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates
por: Theis, JF, et al.
Publicado: (2012)

Similarity of chemokines charge and the V3 domain of HIV-1 env protein.
por: Berkhout, B, et al.
Publicado: (1998)

sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates
por: Lagenaur, Laurel A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5tierlal1uae99aqbmol2cdqhv